跳至主要内容
临床试验/ISRCTN70127774
ISRCTN70127774已完成不适用

Hydroxymethylglutaryl-CoA reductase inhibition in Acute lung injury to Reduce Pulmonary oedema and inflammation: a phase II, single centre, prospective, double-blind, randomised, placebo-controlled trial

The Royal Group Hospitals Trust (UK)0 个研究点目标入组 60 人开始时间: 2006年4月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Mechanically ventilated adult patients admitted to the intensive care unit at the Royal Victoria Hospital, within 48 hours of the onset ALI or ARDS, will be eligible for inclusion in the study. ALI and ARDS will be defined according to the American European Consensus Conference definition.

排除标准

  • Current exclusion criteria as of 17/04/2012
  • 1.Age < 16 years
  • 2.More than 48 hours from the onset of ALI
  • 3.Patient is known to be pregnant
  • 4.CK >10 times the upper limit of the normal range*
  • 5.Transaminases >8 times the upper limit of the normal range*
  • 6.Patients currently receiving ongoing and sustained treatment with any of the following; itraconazole, ketoconazole, HIV protease inhibitors, nefazodone, cyclosporine, amiodarone, verapamil or diltiazem.
  • 7.Patients with severe renal impairment (estimated creatinine clearance less than 30ml/minute) not receiving renal replacement therapy
  • 8.Severe liver disease (Child's Pugh score >12; Appendix 1)
  • 9.Current or recent treatment (within 2 weeks) with statins
  • 10.Physician decision that a statin is required for proven indication
  • 11.Contraindication to enteral drug administration, e.g. patients with mechanical bowel obstruction. Patients with high gastric aspirates due to an ileus are not excluded.
  • 12.Domiciliary mechanical ventilation except for CPAP/BIPAP used for sleep-disordered breathing.
  • 13.Known participation in other investigational medicinal product (IMP) trials within 30 days
  • 14.Consent declined
  • 15.Treatment withdrawal imminent within 24 hours
  • 16.Non-english speaking patients or those who do not adequately understand verbal or written information unless an interpreter is available
  • * If CK, ALT and AST values are not available as part of routine care, a blood sample will be obtained after informed consent but before randomisation.
  • CK, ALT and AST values may be obtained up to 72 hours prior to randomisation.
  • Previous exclusion criteria
  • 1. Aged under 18 years
  • 2. Pregnancy
  • 3. Creatinine kinase (CK) more than five times upper limit of normal range
  • 4. Transaminases more than three times upper limit of normal range
  • 5. Participation in other intervention trials within previous 30 days
  • 6. Current treatment with statins
  • 7. Contraindication to enteral nutrition
  • 8. Unlikely to survive beyond 48 hours
  • 9. Patients with significant end stage disease as previously defined and assent declined from the next of kin

研究者

发起方
The Royal Group Hospitals Trust (UK)

相似试验